Assessment of the abuse liability of buspirone in recreational sedative users.

Author: Bar-TalY, BeakeB, BirdM, ColeJ O, OrzackM H

Paper Details 
Original Abstract of the Article :
The abuse potential of buspirone, a new dopaminergic antianxiety drug, was evaluated by assessing its subjective effects in standard (10 mg) and high (40 mg) doses. These were compared with methaqualone (300 mg), diazepam (20 mg and 10 mg), and placebo in 24 casual recreational sedative users. Addic...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/6130076

データ提供:米国国立医学図書館(NLM)

Investigating the Abuse Liability of Buspirone

This research dives into the potential for abuse of buspirone, a novel dopaminergic antianxiety medication. The study assessed the subjective effects of buspirone in both standard and high doses, comparing its effects to those of methaqualone, diazepam, and a placebo. The research team used the Addiction Research Center Inventory scales to measure various subjective effects, including euphoria, sedation, dysphoria, and abuse liability. The study concluded that buspirone at a high dose was unlikely to be reinforcing to recreational drug users, while the lower dose was indistinguishable from placebo or diazepam.

Buspirone: Not a Potent Reinforcer for Recreational Drug Users

The research found that buspirone at 40 mg did not cause a significant increase in euphoria or abuse liability scores. While the high dose did lead to increased physical sedation and dysphoria, it did not produce the same level of reinforcing effects seen with methaqualone, which is known for its abuse potential. This suggests that buspirone might be less likely to be misused compared to other sedative drugs.

Implications for Prescription and Monitoring

The findings indicate that buspirone might be a safer option for patients seeking treatment for anxiety, as it appears to have a lower potential for abuse than other sedatives. However, it's important to remember that even medications with a lower abuse potential can still be misused. Healthcare providers should carefully monitor patients who are prescribed buspirone, paying close attention to potential signs of misuse or abuse.

Dr.Camel's Conclusion

This research reminds us that even in the vast desert of medication options, it's essential to understand the nuances of each drug's potential for abuse. Like carefully selecting a safe oasis in a vast desert, healthcare providers must carefully choose the right medication and monitor its use to ensure patient safety and well-being.

Date :
  1. Date Completed 1983-03-24
  2. Date Revised 2019-12-10
Further Info :

Pubmed ID

6130076

DOI: Digital Object Identifier

6130076

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.